In addition to the monetary settlement, Stryker has agreed to establish a committee tasked with preventing violations of the False Claims Act and the Foreign Corrupt Practices Act. The shareholder lawsuit stems from previous legal troubles, including Stryker’s recalled Trident hip implant and alleged illegal cross-labeling promotion of a bone putty product.
More Articles on Orthopedic Devices:
Houston Orthopedic and Spine Hospital Now Has Robotic Spine Surgery
32 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in August
Biomet Announces European Launch of Comprehensive Shoulder Device
